Search Results
Test Catalog
TPSF - Overview: Protein, Total, Spinal Fluid
Detecting disruptions of the blood-brain barrier or intrathecal synthesis of immunoglobulins
QUIN - Overview: Quinidine, Serum
Assessing and adjusting quinidine dosage for optimal therapeutic level Assessing quinidine toxicity
SEWB - Overview: Selenium, Blood
Assessment of tissue stores of selenium
CDB - Overview: Cadmium, Blood
Detecting exposure to cadmium, a toxic heavy metal
DIA - Overview: Diazepam and Nordiazepam, Serum
Assessing compliance Monitoring for appropriate therapeutic level Assessing diazepam toxicity
LITH - Overview: Lithium, Serum
Monitoring therapy of patients with bipolar disorders, including recurrent episodes of mania and depression Evaluating lithium toxicity
TPI1 - Overview: Triosephosphate Isomerase Enzyme Activity, Blood
Evaluating individuals with chronic nonspherocytic hemolytic anemia Evaluating individuals with early onset neurologic impairment Genetic counseling for families with triosephosphate isomerase deficiency
SOLFM - Overview: Soluble Fibrin Monomer, Plasma
Assisting in the diagnosis of arterial or venous prethrombotic states in various pathological and clinical situations including disseminated intravascular coagulation/intravascular coagulation and fibrinolysis and postoperative monitoring...
TOBTA - Overview: Tobramycin, Trough, Serum
Monitoring adequate clearance of tobramycin near the end of a dosing cycle
TOBPA - Overview: Tobramycin, Peak, Serum
Monitoring adequacy of serum concentration during tobramycin therapy
CDP - Overview: Chlordiazepoxide and Metabolite, Serum
Monitoring chlordiazepoxide therapy Assessing toxicity
BTBAS - Overview: Butabarbital, Serum
Monitoring of butabarbital therapy
SECOS - Overview: Secobarbital, Serum
Monitoring secobarbital therapy
URCON - Overview: Urea, Random, Urine
Assessment of kidney failure (prerenal vs acute kidney injury)
RPHOC - Overview: Phosphorus, Random, Urine
Evaluation of hypo- or hyperphosphatemic states Evaluation of patients with nephrolithiasis
COL7 - Overview: Anti-Collagen type VII, IgG Antibodies, Serum
Initial screening test in the diagnosis of epidermolysis bullosa acquisita and other immunobullous diseases mediated by collagen VII
ALBSF - Overview: Albumin, Spinal Fluid
Assessment of blood-brain barrier permeability
HEXAZ - Overview: Tay-Sachs Disease, HEXA Gene, Full Gene Analysis, Varies
Second-tier test for confirming a biochemical diagnosis of Tay-Sachs disease (TSD) Carrier testing of individuals with a family history of TSD but an affected individual is not available for testing or disease-causing mutations have not...
AMS - Overview: Amylase, Total, Serum
Diagnosis and management of pancreatitis Evaluation of pancreatic function
BRIVA - Overview: Brivaracetam, Plasma
Assessing compliance and toxicity for brivaracetam
BHYD - Overview: Beta-Hydroxybutyrate, Serum
Monitoring therapy for diabetic ketoacidosis Investigating the differential diagnosis of any patient presenting to the emergency room with hypoglycemia, acidosis, suspected alcohol ingestion, or an unexplained increase in the anion gap...
PAMIK - Overview: Amikacin, Peak, Serum
Monitoring adequacy of serum concentration during amikacin therapy
ACE - Overview: Angiotensin Converting Enzyme, Serum
Evaluation of patients with suspected sarcoidosis
RAMBO - Overview: Ammonium, Random, Urine
Diagnosis of the cause of acidosis using random urine specimens Diagnosis and treatment of kidney stones
METR1 - Overview: Cytochrome b5 Reductase Enzyme Activity, Blood
Evaluation of patients with cyanosis Confirming cases of suspected cytochrome b5 reductase (methemoglobin reductase) deficiency Functional studies in families with cytochrome b5 reductase deficiency
Heavy and light chain pair quantitation may be useful for: 1. Distinguishing between broadly migrating monoclonal proteins and restricted polyclonal immunoglobulin patterns on serum electrophoresis. 2. Quantitating monoclonal IgG proteins...
HEXP - Overview: Iohexol, Plasma
Determining glomerular filtration rate in plasma specimens
HEXU - Overview: Iohexol, Timed Collection, Urine
Determining glomerular filtration rate in urine specimens
CIFST - Overview: Cutaneous Immunofluorescence Antibodies Titer, IgG, Serum
Confirmation of positive IgG anti-cell surface (CS) and anti-basement membrane zone (BMZ) antibodies.
F8IS - Overview: Coagulation Factor VIII Inhibitor Screen, Plasma
Detecting the presence of a specific factor inhibitor directed against coagulation factor VIII
CH8B - Overview: Chromogenic Factor VIII Inhibitor Bethesda Titer, Plasma
Detecting the presence and titer of a specific factor inhibitor directed against coagulation factor VIII This test is not useful for detecting the presence of inhibitors directed against other clotting factors and will not detect the...
CEASF - Overview: Carcinoembryonic Antigen (CEA), Spinal Fluid
Detecting meningeal carcinomatosis and intradural or extradural infiltration Differentiating brain parenchymal metastasis from adenocarcinoma or squamous-cell carcinoma
CK - Overview: Creatine Kinase (CK), Serum
Diagnosing and monitoring myopathies or other trauma, toxin, or drug-induced muscle injury
CRP - Overview: C-Reactive Protein (CRP), Serum
Detecting systemic inflammatory processes Detecting infection and assessing response to antibiotic treatment of bacterial infections Differentiating between active and inactive disease forms with concurrent infection
GABA - Overview: Gabapentin, Serum
Monitoring serum gabapentin concentrations Assessing compliance Adjusting dosage in patients
HICSF - Overview: Histoplasma Antibody Complement Fixation and Immunodiffusion, Spinal Fluid
Aiding in the diagnosis of Histoplasma meningitis using spinal fluid specimens
NOTRP - Overview: Nortriptyline, Serum
Monitoring nortriptyline concentration during therapy Evaluating potential nortriptyline toxicity May aid in evaluating patient compliance
MGS - Overview: Magnesium, Serum
Monitoring preeclampsia patients being treated with magnesium sulfate, although in most cases monitoring clinical signs (respiratory rate and deep tendon reflexes) is adequate and blood magnesium levels are not required
PTFIB - Overview: PT-Fibrinogen, Plasma
Detecting increased or decreased fibrinogen (factor 1) concentration of acquired or congenital origin Differentiating hypofibrinogenemia from dysfibrinogenemia
SSF1 - Overview: Nocardia Stain, Varies
Detecting Nocardia species and other partially-acid fast aerobic actinomycetes in clinical specimens
POU - Overview: Phosphorus, 24 Hour, Urine
Evaluation of hypo- or hyper-phosphatemic states Evaluation of patients with nephrolithiasis
TP - Overview: Protein, Total, Serum
Diagnosis and treatment of a variety of diseases involving the liver, kidney, or bone marrow, as well as other metabolic or nutritional disorders
PINW - Overview: Pinworm Exam, Perianal
Detection of the eggs of Enterobius vermicularis on the skin of the perianal folds
PTMSC - Overview: Prothrombin Time Mix 1:1, Plasma
Screening test to detect a deficiency of 1 or more of the clotting factors of the extrinsic coagulation system (I, II, V, VII, X) due to hereditary deficiency or acquired conditions such as liver disease, vitamin K deficiency, or a specific...
CSPMM - Overview: Plasma Cell Myeloma Pre-Analysis Cell Sorting, Bone Marrow
Pre-analysis cell sorting for the MayoComplete Plasma Cell Myeloma panel
PBR - Overview: Phenobarbital, Serum
Monitoring for appropriate therapeutic concentration of phenobarbital Assessing compliance or toxicity
RCVBS - Overview: Recoverin-IgG Antibody, Immunoblot, Serum
Evaluating patients with suspected paraneoplastic retinopathy accompanying small cell carcinoma
RTSC - Overview: Reptilase Time, Plasma
Evaluation of a prolonged thrombin time (TT): It is mainly used to confirm or exclude the presence of heparin in the specimen or specimen type Evaluating hypofibrinogenemia or dysfibrinogenemia in conjunction with the TT and fibrinogen...
SDEX - Overview: Sickle Solubility, Blood
Screening for presence or absence of hemoglobin (Hb) S (sickle cell disease)
DESPR - Overview: Desipramine, Serum
Monitoring serum concentration of desipramine during therapy Evaluating potential desipramine toxicity May aid in evaluating patient compliance
Site Search
Primary ciliary dyskinesia - Insights
Learn more about Mayo Clinic Laboratories’ robust approach to testing for primary ciliary dyskinesia, a rare genetic condition that can lead to chronic otosinopulmonary disease and infertility in men....
CPT Codes and LOINC Update: September 2019 - Insights
View a full list of new CPT codes, Test Classification Updates, LOINC Codes, and Z-Codes posted to mayocliniclabs.com during the month of September 2019....
https://www.mayocliniclabs.com/it-mmfiles/cpt-code-changes.xlsx
note, CPT Code changes listed on this document are effective January 1st, 2025.*** ***Updates and other changes may occur, and be reflected on this document, leading up to 2025*** ***CPT Code Updates...
MCL Primary Ciliary Dyskinesia Genetic Testing Patient Information MC1235297
MCL Primary Ciliary Dyskinesia Genetic Testing Patient Information Complete print Reset Form Primary Ciliary Dyskinesia Genetic Testing Patient Information Instructions Accurate interpretation reporting...
New communication process for CPT Code changes - Insights
Mayo Clinic Laboratories (MCL) is pleased to announce an essential update to our CPT code communication process and website layout. This change is designed to bring timely notifications for accurate billing...